Stephen Feller

FDA approves new COVID shots, with restrictions

Clinical management of aspergillosis has become more challenging as Aspergillus fumigatus develops increasing resistance to azoles, the antifungals primarily used to treat the infection, according to a review.

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous, shortsighted and tarnishes the legacy of a scientific advancement that saved millions of lives, experts said.

HHS has barred several professional medical organizations from participating as outside liaisons to the CDC’s vaccine advisory committee.

Healio received an APEX award for a 2024 report on the cloudy future of HIV vaccine research in the age of long-acting injectable medications that can protect people from the virus for months at a time.

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with Trump administration priorities, but will apparently leave one critical public health program alone.Republican senators voted to amend the bill to remove a proposed $400 million cut to the U.S. President’s Emergency Plan for AIDS Relief, which had been caught up in

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval to those with at least one underlying condition that puts them at risk for severe disease.

A federal judge this week granted a preliminary injunction to halt mass layoffs at HHS, saying the Trump administration was not authorized to make sweeping changes to an agency created by Congress.

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which could set the stage for the company’s combination COVID-19/influenza shot.

Suriname became the first country in the Amazon region to be declared free of malaria, WHO announced this week.